The immunohistochemistry results in Figure 2E confirmed ADCK2 overexpression in tumors (“T”) of the representative NSCLC patient (Patient-1#, see our previous studies 17, 18), whereas the expression was relatively low in cancer-surrounding normal lung tissues (“N”). Here, ADCK2 is linked to cancer.